|
CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)
In Thousands, except Share data, unless otherwise specified |
12 Months Ended | 159 Months Ended | ||||
|---|---|---|---|---|---|---|
|
Dec. 31, 2013
|
Dec. 31, 2012
|
Dec. 31, 2013
|
||||
| Operating costs and expenses: | ||||||
| Research and development, net (Note 9) | $ 2,917 | $ 1,770 | $ 29,106 | [1] | ||
| General and administrative | 2,101 | 1,748 | 20,852 | [1] | ||
| Total operating costs and expenses | 5,018 | 3,518 | 49,958 | [1] | ||
| Financial expense (income), net | (144) | (93) | 2,310 | [1] | ||
| Other income | 0 | 0 | (132) | [1] | ||
| Operating loss | 4,874 | 3,425 | 52,136 | [1] | ||
| Taxes on income (Note 10) | 25 | 5 | 107 | [1] | ||
| Loss from continuing operations | 4,899 | 3,430 | 52,243 | [1] | ||
| Net loss from discontinued operations | 0 | 0 | 164 | [1] | ||
| Net loss | $ 4,899 | $ 3,430 | $ 52,407 | [1] | ||
| Basic and diluted net loss per share from continuing operations (in dollars per share) | $ 0.03 | $ 0.02 | $ 0 | [1] | ||
| Weighted average number of shares outstanding used in computing basic and diluted net loss per share (in shares) | 161,071,968 | 137,596,391 | 0 | [1] | ||
|
||||||